Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 245.0 | 193.3 | 148.3 | 105.1 |
| Revenue growth | 26.7% | 30.3% | 41.1% | |
| Cost of goods sold | 53.9 | 46.7 | 39.2 | 30.7 |
| Gross profit | 191.1 | 146.6 | 109.1 | 74.5 |
| Gross margin | 78.0% | 75.9% | 73.6% | 70.8% |
| Sales and marketing | 176.3 | 127.7 | 87.2 | 75.0 |
| Research and development | 59.5 | 48.2 | 31.6 | 26.6 |
| General and administrative | 65.2 | 48.6 | 33.5 | 22.1 |
| EBITA | -109.4 | -77.5 | -43.1 | -49.0 |
| EBITA margin | -44.6% | -40.1% | -29.1% | -46.6% |
| Amortization of intangibles | 0.5 | 0.3 | 0.0 | 0.3 |
| EBIT | -109.8 | -77.8 | -43.2 | -49.3 |
| EBIT margin | -44.8% | -40.2% | -29.1% | -46.9% |
| Pre-tax income | -104.5 | -77.8 | -43.3 | -48.8 |
| Income taxes | 3.8 | 2.5 | 1.7 | 1.3 |
| Net income | -107.6 | -79.1 | -43.7 | -49.4 |
| Net margin | -43.9% | -40.9% | -29.5% | -47.0% |
| |
| Diluted EPS | ($1.26) | ($1.53) | ($3.31) | ($4.11) |
| Shares outstanding (diluted) | 85.1 | 51.8 | 13.2 | 12.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|